- Report
- August 2025
- 197 Pages
Global
From €3153EUR$3,545USD£2,707GBP
€3503EUR$3,939USD£3,008GBP
- Report
- August 2025
- 194 Pages
Global
From €3153EUR$3,545USD£2,707GBP
€3503EUR$3,939USD£3,008GBP
- Report
- July 2025
- 200 Pages
Europe
From €2215EUR$2,490USD£1,901GBP
- Report
- August 2025
Global
From €4358EUR$4,900USD£3,741GBP
- Report
- July 2025
- 100 Pages
Global
From €4358EUR$4,900USD£3,741GBP
From €4358EUR$4,900USD£3,741GBP
- Report
- April 2025
- 120 Pages
United States
From €4358EUR$4,900USD£3,741GBP
- Report
- December 2022
- 223 Pages
Global
From €2335EUR$2,625USD£2,004GBP
€4669EUR$5,250USD£4,009GBP
- Report
- August 2025
- 180 Pages
Global
From €3153EUR$3,545USD£2,707GBP
€3503EUR$3,939USD£3,008GBP
- Report
- December 2024
- 82 Pages
India
From €3113EUR$3,500USD£2,672GBP
- Report
- July 2024
- 82 Pages
India
From €3113EUR$3,500USD£2,672GBP
- Report
- May 2024
- 184 Pages
Global
From €4002EUR$4,500USD£3,436GBP
- Report
- July 2023
- 78 Pages
United States
From €3113EUR$3,500USD£2,672GBP
- Report
- July 2025
- 188 Pages
Global
From €4002EUR$4,500USD£3,436GBP
- Report
- September 2024
- 82 Pages
Japan
From €3113EUR$3,500USD£2,672GBP
- Report
- July 2024
- 150 Pages
Global
From €3335EUR$3,750USD£2,863GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2668EUR$3,000USD£2,291GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2668EUR$3,000USD£2,291GBP
- Report
- February 2024
- 117 Pages
Global
From €4225EUR$4,750USD£3,627GBP
- Report
- July 2024
- 150 Pages
Global
From €3335EUR$3,750USD£2,863GBP

The Prostate Specific Antigen (PSA) market is a segment of the Diagnostics industry that focuses on the detection of prostate cancer. PSA tests measure the amount of PSA in a patient's blood, which can be an indicator of prostate cancer. PSA tests are typically used in conjunction with other tests, such as digital rectal exams, to diagnose prostate cancer. PSA tests are also used to monitor the progression of prostate cancer in patients who have already been diagnosed.
The PSA market is highly competitive, with a number of companies offering PSA tests. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Other companies in the market include Becton Dickinson, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more